Form D · Pharmaceuticals

Effcon MXR LLC

Atlanta, GA · CIK 0001474397

Offering snapshot reported Aug 16, 2012 · SEC filing

Reported sold
Yet to sell
Offering amount: $2.28M
Investors reported
0
Form D · investor count
Minimum accepted
$50K
Reported outside-investor minimum
First sale
Yet to occur
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 16, 2012InitialYet to sellNo comparison0SEC filing
Jun 27, 2011Amendment$721,566$199,800vs Oct 18, 20108SEC filing
Oct 18, 2010Initial$521,766No comparison5SEC filing
Oct 16, 2009AmendmentYet to sellNo comparison0SEC filing
Oct 15, 2009InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$45K (estimated)
Finders' fees
$0
Form D file number
021-182842
Units are offered on a "best efforts" basis by issuer without compensation/commission. Issuer may permit one or more broker/dealers to refer clients. Issuer will pay commission to such broker/dealers in a negotiated amount not exceeding 5% of investment.

Source: Form D, filed Aug 16, 2012. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Ed Burklow Director, Executive, Promoter
Hal Folds Director, Promoter
Harris "Bo" Simpson Director, Executive, Promoter

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
4200 Northside Parkway Building 11, Suite 100
Atlanta, GA, 30327